Fibrin‐specific poly(N‐isopropylacrylamide) nanogels for targeted delivery of tissue‐type plasminogen activator to treat thrombotic complications are well tolerated in vivo

Targeted drug delivery for maintaining blood fluidity can reduce the risks associated with systemic anticoagulants that can lead to off‐target bleeding. Recently, there has been much interest in targeted delivery of tissue‐type plasminogen activator (tPA) for treating thrombotic complications. The w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihalko, Emily P., Nellenbach, Kimberly, Krishnakumar, Manasi, Moiseiwitsch, Nina, Sollinger, Jennifer, Cooley, Brian C., Brown, Ashley C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115681/
https://www.ncbi.nlm.nih.gov/pubmed/35600656
http://dx.doi.org/10.1002/btm2.10277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115681/
https://www.ncbi.nlm.nih.gov/pubmed/35600656
http://dx.doi.org/10.1002/btm2.10277

Ejemplares similares